Welcome to LookChem.com Sign In|Join Free

CAS

  • or

206193-17-1

Post Buying Request

206193-17-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

206193-17-1 Usage

Description

(R)-3-bromo-N-(4-cyano-3-trifluoromethylphenyl)-2-hydroxy-2-methylpropionamide is a complex chemical compound with the molecular formula C11H11BrF3N2O2. It is characterized by the presence of a bromo group, a cyano group, and a trifluoromethylphenyl group, all attached to a 2-hydroxy-2-methylpropionic acid derivative. (R)-3-broMo-N-(4-cyano-3-trifluoroMethylphenyl)-2-hydroxy-2-MethylpropionaMide is of interest in pharmaceutical research and development due to its potential biological activity and may serve as a key component in the synthesis of other chemical compounds.

Uses

Given the limited information provided and the need for further research to fully understand its properties and potential applications, the following uses are speculative and based on the compound's structural features:
Used in Pharmaceutical Research and Development:
(R)-3-bromo-N-(4-cyano-3-trifluoromethylphenyl)-2-hydroxy-2-methylpropionamide is likely used as a chemical intermediate for the synthesis of pharmaceutical compounds. Its unique structure, including the bromo and trifluoromethyl groups, may contribute to its potential as a building block for creating novel drugs with specific biological activities.
Used in Chemical Synthesis:
In the chemical industry, (R)-3-bromo-N-(4-cyano-3-trifluoromethylphenyl)-2-hydroxy-2-methylpropionamide could be utilized as a starting material or a reagent in the synthesis of various organic compounds, particularly those with potential applications in the pharmaceutical, agrochemical, or materials science sectors.
Please note that without specific details on the compound's applications, these uses are based on the general properties of similar compounds and the potential for such a molecule to be involved in the pharmaceutical and chemical industries. Further research and development would be necessary to confirm these potential uses.

Check Digit Verification of cas no

The CAS Registry Mumber 206193-17-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,6,1,9 and 3 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 206193-17:
(8*2)+(7*0)+(6*6)+(5*1)+(4*9)+(3*3)+(2*1)+(1*7)=111
111 % 10 = 1
So 206193-17-1 is a valid CAS Registry Number.

206193-17-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R)-3-bromo-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide

1.2 Other means of identification

Product number -
Other names R-2

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:206193-17-1 SDS

206193-17-1Downstream Products

206193-17-1Relevant articles and documents

Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer

He, Yali,Hwang, Dong-Jin,Ponnusamy, Suriyan,Thiyagarajan, Thirumagal,Mohler, Michael L.,Narayanan, Ramesh,Miller, Duane D.

, p. 11045 - 11062 (2021/08/03)

A series of propanamide derivatives were designed, synthesized, and pharmacologically characterized as selective androgen receptor degraders (SARDs) and pan-antagonists that exert a broad-scope androgen receptor (AR) antagonism. Incorporating different ba

PYRAZOLYLPROPANAMIDE COMPOUNDS AND USES THEREOF FOR TREATMENT OF PROSTATE CANCER

-

Paragraph 00194; 00192, (2021/10/11)

This invention relates to pyrazolylpropanamide compounds and uses thereof for treatment of prostate cancer, advanced prostate cancer, refractory prostate cancer, AR overexpressing prostate cancer, castration-resistant prostate cancer, castration-sensitive

Synthesis method of nicotinate

-

Paragraph 0026-0033; 0047-0055; 0068-0075, (2020/05/01)

The invention belongs to the technical field of compound preparation, and in particular, relates to (S)-1-((4-cyano-3-(trifluoromethyl)phenyl)amino)-3-(4-cyanophenoxy)-2-methyl-1-oxopropan-2-yl nicotinate and a synthesis method thereof. The method compris

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 206193-17-1